SAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech and big pharma. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

The Retinal Imaging Biomarkers & Endpoints Summit will provide a unique opportunity to gather with leading imaging biomarker experts from the likes of Janssen, Apellis, Novartis and Boehringer Ingelheim to collaboratively discuss the field's most pressing challenges to successfully implement novel, more sophisticated imaging technologies into therapeutic development to advance retinal assessments, streamline translation and shorten drug development timelines.

Connect in Pharma is a thought-provoking free-of-charge event for professionals from the whole value chain of the pharma and biopharma industry. Pharmaceutical companies, governmental bodies, CMOs & CDMOs, API manufacturers, suppliers and experts in the pharmaceutical supply chain will gather for two days in Geneva to see what is coming next in the downstream process.

The hotly anticipated Next Generation Inhalation Delivery Summit will debut, where we will unite 80+ senior leaders at this definitive meeting dedicated to the inhalation community. Whether your work in COPD, asthma, IPF, lung cancer or infectious disease, this comprehensive forum offers the solution to capitalize on the common goal of targeted lung delivery.

The RESCON EUROPE 2023 highlights innovations in the respiratory sector and connected devices. At the event we will showcase new trends in aerosol science and the future directions of inhalation drug delivery research.

At the first conference dedicated to soft mist inhalers (SMIs), learn from key opinion leaders with extensive experience in the field of inhaled drug delivery how to make, develop, use, file and launch SMIs, and their place in an inhaled therapy portfolio. The event will include talks on device technology, regulatory and practical aspects of formulating and testing SMIs, leachables and extractable science for SMIs, and human factors studies.

The 4th RNA Editing Summit returns as the only industry-dedicated meeting, bringing together 80+ Directors, Heads and VPs of Platform Biology, Genetic Medicines, Discovery, RNA Technologies and Innovations. This is your unmissable chance to hear how the RNA editing field is progressing with limitless therapeutic and clinical potential.

The 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns this August (Boston, MA) to unite 140+ biopharma thought leaders in the field all racing to uncover the potential of lipid-delivery properties. This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.

The marcus evans 14th Biologics Formulation, Development and Drug Delivery conference will explore techniques in stability formulation for high-concentration proteins from leading biotech companies. Learn how to tackle key challenges in developing drugs and enhance patient delivery on a larger scale, improve the quality and control of drug manufacturing, and boost the responsiveness in producing long-acting drugs to match global needs.

The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry.

Overcoming challenges in formulation, device design and patient compliance are the keys to your organization's ability to leverage products in the inhalation drug delivery market. Pharma Ed's Inhalation Drug Delivery Summit brings together today's leading researchers from both industry and academia to share the latest knowledge in drug and device development, from pre-clinical R&D through phase trials.

The drug delivery industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss Pharma Ed’s Microneedle & Transdermal Drug Delivery Forum. Leading researchers from industry and academia come together to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Medical Technology Ireland takes place on 20-21 September 2023 at Galway Racecourse. Don't miss over 250 global suppliers exhibiting across four floors; an inspiring and educational two-day Conference; the highly popular Women in MedTech Forum; and unrivalled networking and business opportunities.

RESCON SUMMIT 2023 will feature key case studies on the latest trends in Sustainable Inhalation devices, Inhaled mRNA Therapy, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilisation, and aseptic process simulation (or media fill). The Aseptic Processing Summit includes expert insight into the robust aseptic processing requirements facing the industry, and covers implementation and management of best practice aseptic, barrier, containment, and aseptic technologies.

The 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference returns to Europa. Under the theme "20 Years of Innovation in Drug Delivery - What's next?" we are celebrating the 20th conference edition. Await scientific presentations from regulatory authorities and industry, ample discussions as well as multiple networking opportunities.

Smithers have been organising of the Extractables & Leachables conferences for over 15 years, ensuring that this conference will provide you with current information and a great conference experience. Given the current scrutiny paid by governing bodies, understanding the best practice to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.

Projected to hit US$8 billion by the end of 2024 in the US alone, the market for PFS and autoinjectors continues to grow fast. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing make PFS & autoinjectors attractive. Growth in the biologics market, rising preference for self-administrations which use PFS, pen injectors, and autoinjectors, are propelling the growth. This is why you cannot afford to miss Pharma Ed Resources’ Pre-filled Syringes & Auto-Injectors Forum, which brings together thought-leaders and key decision makers over two days.

Join the world's leading experts in Inhalation and Respiratory Drug Delivery at the 7th annual conference in Milan, Italy. On November 23-24, 2023, medical, pharmacology, and healthcare specialists will gather to discuss the latest advancements and techniques in respiratory drug delivery. Don't miss this opportunity to expand your knowledge and network with industry leaders. Register now!

Get up-to-date on the latest analytical strategies and regulatory updates at the Extractables & Leachables Conference on December 4-5, 2023, in Prague. Join scientists, toxicologists, and E&L managers to explore risk-based E&L programs, chemical characterization, and toxicological risk assessment. With discussions on medical device materials and custom-made mechanisms, this conference is essential for all involved in E&L. Register now to stay ahead of the curve!

The DDL Conference is a premier international conference covering respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts, and comprises lectures, posters and exhibitions with numerous networking opportunities. DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists.